EUVIMEDEUVIMED entdecken
Crossref

The Potential of Menstrual Blood-Derived Extracellular Vesicles (MenMSC-Evs) in Combination with Platelet-Rich Fibrin (PRF) as a Biological Adjuvant for Improving Full-Thickness Wound Healing

Maryam Rahnama, Fariba Abbasi, Parviz Ranjbarvan, Ali Golchin

Stem Cell Reviews and Reports · 2026

DOI: 10.1007/s12015-025-11007-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Stem Cell Reviews and Reports, 2026. Verfasst von Maryam Rahnama und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Applied Cell Sciences, School of Medicine, Urmia University of Medical Sciences, Urmia, Iran. Hauptthemen laut MEDLINE: Wound Healing, Extracellular Vesicles, Platelet-Rich Fibrin, Mesenchymal Stem Cells. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 74 Literaturangaben. Gefördert von: Urmia University of Medical Sciences, Iran, Council for Development of Regenerative Medicine and Stem Cells Technologies, Iran.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Full-thickness wound healing, particularly in chronic wounds, has remained a significant clinical challenge due to limited regenerative therapies and immune responses. Although the different biologic-based combination therapies have been suggested, the effective and safe biological adjuvants require further research and development to optimize their potential for wound healing. This study investigates the synergistic effect of menstrual blood mesenchymal stem cell-derived extracellular vesicles (MenMSC-Evs) combined with platelet-rich fibrin (PRF) on full-thickness wound healing. In this context, the MenMSC-Evs and PRF were first assessed in vitro (n = 3) for their antibacterial efficacy against E. coli, S. aureus, and P. aeruginosa. The impact of MenMSC-Evs on the proliferation and migration of HUVECs and NIH3T3 cells was evaluated to determine their influence on cellular behaviors. In vivo, a full-thickness excisional wound model was established on nine Wistar rats, with four wounds per rat assigned to different treatment groups, to evaluate wound healing. In vitro, MenMSC-Evs significantly enhanced the proliferation and migration of HUVECs by 29.3% and 11.5%, respectively, and NIH3T3 cells by 24.7% and 8.5% (p < 0.01, p < 0.001). PRF-Evs also demonstrated improved antibacterial activity, particularly against S. aureus (p < 0.001). In vivo, PRF-Evs accelerated wound closure by 23.2% (p < 0.001), increased collagen deposition (p < 0.001), and promoted angiogenesis, as evidenced by a 1.9-fold increase in VEGF-A expression and a 3.1-fold rise in CD34-positive microvessel density (p < 0.001). Moreover, PRF-Evs modulated macrophage polarization by reducing pro-inflammatory cytokines-IL-1β (8.2-fold) and TNF-α (4.4-fold)-while upregulating anti-inflammatory cytokines, including IL-10 (3.2-fold) and TGF-β (2.7-fold) (p < 0.001). In conclusion, these findings indicate that the novel combination of MenMSC-Evs and PRF offers a promising cell-free therapeutic strategy for chronic wound management by enhancing immunomodulation, promoting neovascularization, and facilitating tissue regeneration.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Wound HealingExtracellular VesiclesPlatelet-Rich FibrinMesenchymal Stem CellsMenstruationAnimalsHumansFemaleMiceNIH 3T3 CellsRatsCell ProliferationCell MovementRats, WistarHuman Umbilical Vein Endothelial Cells

Stichwörter der Autor:innen

Extracellular vesiclesMenstrual blood-derived mesenchymal stem cellsPlatelet-rich fibrinRegenerative therapyWound healing

Autor:innen und Institutionen

  • Department of Applied Cell Sciences, School of Medicine, Urmia University of Medical Sciences, Urmia, Iran.
  • Solid Tumor Research Center, Cellular and Molecular Medicine Institute, Urmia University of Medical Sciences, Urmia, Iran.
  • Department of Applied Cell Sciences, School of Medicine, Urmia University of Medical Sciences, Urmia, Iran. agolchin.vet10@yahoo.com.
  • Cellular and Molecular Research Center, Cellular and Molecular Medicine Research Institute, Urmia University of Medical Sciences, Urmia, Iran. agolchin.vet10@yahoo.com.

Förderung

  • Urmia University of Medical Sciences, Iran
  • Council for Development of Regenerative Medicine and Stem Cells Technologies, Iran

Zitieren

APA

Rahnama, M., Abbasi, F., Ranjbarvan, P., & Golchin, A. (2026). The Potential of Menstrual Blood-Derived Extracellular Vesicles (MenMSC-Evs) in Combination with Platelet-Rich Fibrin (PRF) as a Biological Adjuvant for Improving Full-Thickness Wound Healing. Stem Cell Reviews and Reports. https://doi.org/10.1007/s12015-025-11007-2

Vancouver

Rahnama M, Abbasi F, Ranjbarvan P, Golchin A. The Potential of Menstrual Blood-Derived Extracellular Vesicles (MenMSC-Evs) in Combination with Platelet-Rich Fibrin (PRF) as a Biological Adjuvant for Improving Full-Thickness Wound Healing. Stem Cell Reviews and Reports. 2026. doi:10.1007/s12015-025-11007-2

BibTeX
@article{Rahnama2026,
  author = {Rahnama, Maryam and Abbasi, Fariba and Ranjbarvan, Parviz and Golchin, Ali},
  title = {The Potential of Menstrual Blood-Derived Extracellular Vesicles (MenMSC-Evs) in Combination with Platelet-Rich Fibrin (PRF) as a Biological Adjuvant for Improving Full-Thickness Wound Healing},
  journal = {Stem Cell Reviews and Reports},
  year = {2026},
  doi = {10.1007/s12015-025-11007-2}
}
Kostenlos starten →